NCT00286793 2011-06-29Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPCAscenta TherapeuticsPhase 1/2 Completed76 enrolled
NCT00571675 2010-11-09A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)Ascenta TherapeuticsPhase 2 Completed220 enrolled